Filters
Thulium (ThuLEP) compared with holmium (HoLEP) laser enucleation of prostate yields faster symptom improvement and better safety outcomes in patients with benign prostatic hyperplasia (BPH), a recent meta-analysis has found.
Concomitant gastrointestinal (GI) infections contribute to more severe symptoms in patients with immune-mediated diarrhoea and colitis (IMDC), a recent study has shown. Antimicrobial therapy neither shuns the need for immunosuppressive treatment for IMDC nor improves clinical outcomes.
Later-line chemotherapy does not seem to improve oral intake in patients with advanced gastric cancer (AGC), which is why careful adaptation of regimens is necessary for those at risk for impaired oral intake, suggests a recent study.
Men receiving hormone therapy for prostate cancer usually report arterial vascular events, according to a retrospective analysis of a pharmacovigilance database. Moreover, use of gonadotropin releasing hormone (GnRH) antagonists results in fewer overall cardiovascular (CV) and arterial vascular events compared with GnRH agonists.
Circulating levels of serum microRNAs (miRNAs) show potential for the timely detection of early-stage ovarian cancer, a recent study has found.
A patient’s sex and comorbidity status are important factors to consider in determining the age at which to discontinue surveillance of nondysplastic Barrett’s oesophagus (NDBE), a recent study has found.
Due to the immunosuppression associated with B-cell chronic lymphocytic leukaemia (CLL), immune responses elicited after the first and second dose of vaccines for the coronavirus disease 2019 (COVID-19) are substantially reduced in these patients, a recent study has found.
Preoperative initiation of dietitian support and patient satisfaction level with dietitian support do not affect long-term postoperative weight loss and nutrition impact symptoms (NIS) in patients operated for oesophageal cancer, a study has found.
Different Janus kinase (JAK) inhibitors exhibit differing degrees of efficacy and tolerability against myelofibrosis, a recent meta-analysis has found. In particular, ruxolitinib appears to be the best choice and is a good option as the reference JAK inhibitor.
Alcohol intake appears to be a strong risk factor for cancer, while dairy, fruits and vegetables, and coffee exert protective effects, reveals a recent umbrella review of meta-analyses of observational studies.
